HCSG remains in a Medium-Term bullish advance under Stage 2, supported by continuation patterns, but near-term overbought and exhaustion signals advise waiting for a pullback into rising EMA support before engaging.
↑Q1 revenue reached $462.8M (+3.4% YoY), EPS $0.37 vs $0.22 est.
↑Cost of services at 83.6% of revenue (target 86%), boosting margins.
↓Analyst revisions have turned negative, weighing on forward outlook.
